Hemolytic disease of the newborn (also called erythroblastosis fetalis) is a serious condition that may occur when the blood types of a mother and her baby do not match. Substances (antibodies) in the mother's blood cross the placenta and may destroy the red blood cells of the fetus.
After birth, a baby with hemolytic disease may be treated with a blood transfusion.
Current as of: July 26, 2016
Author: Healthwise Staff
Medical Review: Sarah Marshall, MD - Family Medicine & William Gilbert, MD - Maternal and Fetal Medicine
To learn more about Healthwise, visit Healthwise.org.
© 1995-2016 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Donations to UW Health are managed by the University of Wisconsin Foundation, a publicly supported charitable organization under 501(c)(3) of the Internal Revenue Code.